MENU
PHVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pharvaris (PHVS) Ownership - Who owns Pharvaris?
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks... Show more
Profile
Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
65
Web
https://www.pharvaris.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.43B
P/E Ratio
N/A
Total Cash
236.5M
Projected Growth
N/A
Total Debt
740.98K
Revenue
N/A
Risk (Beta)
-4.27
Dividend Yield
N/A
Total Cash/Share
3.68
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PHVS
Capitalization
1.43B
P/E Ratio
N/A
Risk (Beta)
-4.27
Dividend Yield
N/A
Total Cash
236M
Total Cash/Share
3.68
Total Debt
741K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
225M
P/B Ratio
6.64
Cash Flow
N/A
Earnings
-2.81
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.54M
Current Ratio
11.10
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-159.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.76
Shares Held By Institutions
100M
Shares Outstanding - Current
64.3M
Total Liabilities
22.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
19.927
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHVS showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
65
Web
https://www.pharvaris.com